Literature DB >> 14767150

Alexithymia and psychopathology in patients with psychiatric and functional gastrointestinal disorders.

Piero Porcelli1, Valeria Affatati, Antonello Bellomo, Massimo De Carne, Orlando Todarello, Graeme J Taylor.   

Abstract

BACKGROUND: Alexithymia and psychopathology may influence the way individuals experience psychological distress and somatic symptoms. This study evaluated patients referred to psychiatric and gastroenterologic outpatient settings in order to investigate the levels of alexithymia and psychopathology, and the possible role of alexithymia in symptom perception and health care utilization. The association between psychiatric disorders and functional gastrointestinal disorders (FGIDs) was also assessed.
METHODS: Psychopathology (by the Revised 90-item Symptom Checklist), alexithymia (by the 20-item Toronto Alexithymia Scale), and gastrointestinal symptoms (by the Gastrointestinal Symptom Rating Scale) were evaluated in 52 psychiatric outpatients and 58 medical outpatients with FGIDs. Two comorbid subgroups of 25 psychiatric patients with FGIDs and 38 FGID patients with psychiatric disorders were formed and compared.
RESULTS: Forty-eight percent of the psychiatric patients had associated FGIDs, and 65.5% of the FGID patients had associated psychiatric disorders. The FGID patients had significantly less psychopathology, but significantly higher alexithymia and more severe gastrointestinal symptoms, than the psychiatric patients. In the comparison of the two subgroups with comorbidity, FGID patients with psychiatric disorders were still more alexithymic and had less psychopathology than psychiatric patients with FGIDs, but gastrointestinal symptoms were not significantly different.
CONCLUSION: Patients with 'functional' gastrointestinal symptoms attending a medical care service are likely to be highly alexithymic, whereas those attending a psychiatric care service are likely to show severe psychopathology. Alexithymia seems to influence the presentation of 'functional' somatic symptoms and the type of health care utilization. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2004        PMID: 14767150     DOI: 10.1159/000075539

Source DB:  PubMed          Journal:  Psychother Psychosom        ISSN: 0033-3190            Impact factor:   17.659


  7 in total

1.  Treatment effects of partially hydrolyzed guar gum on symptoms and quality of life of patients with irritable bowel syndrome. A multicenter randomized open trial.

Authors:  Giancarlo Parisi; Enrico Bottona; Maurizio Carrara; Fabrizio Cardin; Alessandra Faedo; Dario Goldin; Marco Marino; Maurizio Pantalena; Gianni Tafner; Giorgio Verdianelli; Maurizio Zilli; Gioacchino Leandro
Journal:  Dig Dis Sci       Date:  2005-06       Impact factor: 3.199

2.  Association of alexithymia and depression symptom severity in adults aged 50 years and older.

Authors:  Patricia M Bamonti; Marnin J Heisel; Raluca A Topciu; Nathan Franus; Nancy L Talbot; Paul R Duberstein
Journal:  Am J Geriatr Psychiatry       Date:  2010-01       Impact factor: 4.105

3.  The effectiveness of cognitive behavior stress management on functional dyspepsia symptoms.

Authors:  Zahra Dehghanizade; Yadolah Zargar; Mahnaz Mehrabizadeh Honarmand; Ahmad Kadkhodaie; Majid Eydi Baygi
Journal:  J Adv Med Educ Prof       Date:  2015-04

4.  It's in the mix: psychological distress differs between combinations of alexithymic facets.

Authors:  Elif Alkan Härtwig; Claudia Crayen; Isabella Heuser; Michael Eid
Journal:  Front Psychol       Date:  2014-11-12

5.  Alexithymia in Gastroenterology and Hepatology: A Systematic Review.

Authors:  Danilo Carrozzino; Piero Porcelli
Journal:  Front Psychol       Date:  2018-04-06

6.  Association Between Alexithymia and Functional Gastrointestinal Disorders.

Authors:  Michiko Kano; Yuka Endo; Shin Fukudo
Journal:  Front Psychol       Date:  2018-04-25

7.  Impaired emotion recognition is linked to alexithymia in heroin addicts.

Authors:  Giuseppe Craparo; Alessio Gori; Stefano Dell'Aera; Giulia Costanzo; Silvia Fasciano; Antonia Tomasello; Carmelo M Vicario
Journal:  PeerJ       Date:  2016-04-05       Impact factor: 2.984

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.